curriculum vitae martha f. rogers, md, faap rank
TRANSCRIPT
Martha F. Rogers, M.D., FAAP – August 2012
1
MARTHA F. ROGERS, MD, FAAP Rank: Research Professor
Director, Lillian Carter Center for Global Health & Social Responsibility Nell Hodgson Woodruff School of Nursing
Emory University Telephone: (404) 727-8424 Email: [email protected]
Alternate address: 325 Swanton Way
Decatur, GA 30030 [email protected]
Tel: 404-592-1431 Mobile: 404-358-1033
EDUCATION Dates Institution and Location Degree
1972-1976 Medical College of Georgia Medical Doctor
1969-1972 Emory University Pre-Med
LICENSES AND CERTIFICATIONS Dates Type License Number
1981 – 5/2015 Composite State Board of Medical Examiners #031315
1981 Fellow, American Academy of Pediatrics
1983 Board Eligible for Preventive Medicine
HONORS AND AWARDS Year Name of Award
1999 Certificate of Commendation, American Academy of Pediatrics
1999 Dept of Health and Human Services Secretary’s Award for Distinguished Service
1984, 1990, and 1992 US Public Health Service Unit Commendation (3 awards)
1986 and 1989 US Public Health Service Commendation Medal (2 awards)
1989, 1994 and 1996 US Public Health Service Outstanding Unit Citation (3 awards)
1989 US Public Health Service Outstanding Service Medal
1989, 1990, 1993, 1996 and 1997
Nominated, Centers for Disease Control and Prevention Charles W. Sheppard Award for outstanding scientific publication
Martha F. Rogers, M.D., FAAP – August 2012
2
1992 Regular US Public Health Service Commissioned Corps Appointment
1992 Surgeon General's Exemplary Service Medal
1993 National Center for Infectious Disease Research, Epidemiology and Laboratory Award for Investigation of Idiopathic CD4 T-lymphocytopenia
1993 US Public Health Service Meritorious Service Award
PROFESSIONAL POSITIONS Month, Year Position Institution June 2008-present Director Lillian Carter Center for Global
Health and Social Responsibility
Nov 2002-present Research Professor Nell Hodgson Woodruff School of Nursing, Emory University
June 2001 - present Director, AIDS Programs
Task Force for Global Health
Jun 2001- June 2001 Senior Scientist Task Force for Global Health
Sept 1997-Jun 2000 Associate Director for Science Centers for Disease Control and Prevention
Mar 1989-Sept 1997 Chief, Epidemiology Branch Centers for Disease Control and Prevention
Mar 1984-Feb 1989 Chief, Pediatric and Family Studies Centers for Disease Control and Prevention
Jun 1981-Mar 1984 EIS Officer Centers for Disease Control and Prevention
Jul 1976-Jun 1979 Pediatric Residency Phoenix Hospitals Affiliated Pediatric Program
SCHOLARSHIP: GRANTS AND OTHER FUNDING
Research Grants Under Review (in reverse chronological order)
Educational, Training, and Program Grants Funded (in reverse chronological order) African Health Workforce Project (M Rogers) Role and effort: PI, 35% effort Grant number: S5033 Funding agency: CDC, Associated Schools of Public Health Total costs: $800,000/year
Martha F. Rogers, M.D., FAAP – August 2012
3
Funding period: 8/15/2012 – 8/14/2017 Review of manuscripts and protocols Role and effort : Consultant, 35% Grant number: IPA Funding agency: CDC Div HIV/AIDS Total costs: 30% of annual salary Funding period: 6/30/2005 – present Review of manuscripts and protocols Role and effort : Consultant, 20% Grant number: IPA Funding agency: CDC Global AIDS Programs Total costs: 20% of annual salary Funding period: 6/30/2008 – present Kenya Health Workforce Project (M. Rogers) Role and effort : PI, 30% effort Grant number: S3800 Funding agency: CDC, Associated Schools of Public Health Total costs: $5,207,769 Funding period: 9/27/2006 – 9/26/2012 Development of Interventions for Multiply at Risk Groups for HIV (M. Rogers, PI) Role and effort: Project Director ; 15% effort Grant number: contract number 200-2010-34748 Funding agency: CDC Global AIDS Program Total cost: $245,000 Funding period: 6/1/2010 – 6/6/2012 Project Enhance (M. Rogers, PI) Role and effort : Project Director, (25%) Grant number: contract number 200-2009-M-31762 Funding agency: CDC Global AIDS Program Total cost: $250,000 Funding period: 8/20/2009 – 5/23/2011 Prevention with Positives (M. Rogers, PI) Role and effort: Director, 30% effort Grant number: contract number GS-ooF-0001T Funding agency: CDC Global AIDS Program Total costs: $700,000 Funding period: 12/29/2006 – 9/15/2010 African Children Orphaned and At-risk for AIDS (Mark Aguirre, PI) Role and effort : Consultant, 10% Grant number: Funding agency: HOPE Worldwide OVC Program
Martha F. Rogers, M.D., FAAP – August 2012
4
Total costs: $100,000 Funding period: 5/30/2006 – 4/15/2008 TB/HIV Training Program (M. Rogers) Role and effort : Contract Director, 10% effort Grant number Funding agency: CDC Global AIDS Program Program Total costs: $115,000 Funding period: mm/dd/2005 –mm/dd/2006 Diagnosing Infants with HIV (M. Rogers) Role and effort: Contract Director, 20% Grant number Funding agency: CDC Global AIDS Program Total costs: $110,000 Funding period: mm/dd/2005 – mm/dd/2006 Socioemotional Development Conference (M. Rogers) Role and effort: Project Director, 5% Grant number Funding agency: Georgia Department of Early Learning (2 contracts) Total costs: $150,000 Funding period: mm/dd/2005 – mm/dd/2006 Engaging Parents (M.Rogers) Role and effort : Project Director, 10% Grant number Funding agency: Georgia Division of Public Health Total costs: $135,000 Funding period: mm/dd/2005 – mm/dd/2006 Video production for Parenting in the Real World (M. Rogers) Role and effort : Project Director, 15% effort Grant number Marguerite Casey Foundation Total costs: $40,000 Funding period: mm/dd/2004 – mm/dd/2005 Counselor Training for Couples Counseling (M. Rogers) Role and effort: Project Director, 30% effort Grant number Funding agency: CDC Global AIDS Program Total costs: $250,000 Funding period: mm/dd/2004 – mm/dd/2005 Parenting in the Real World (M. Rogers) Role and effort : Project Director, 30% effort Grant number
Martha F. Rogers, M.D., FAAP – August 2012
5
Funding agency: GA Dept of Early Learning Total costs: $350,000 Funding period: mm/dd/2004 – mm/dd/2005 Enhancing Early Childhood Comprehensive Systems (M. Rogers) Role and effort : Contractor, 5% effort Grant number Funding agency: Georgia Department of Human Resources Total costs: $10,000 Funding period: 9/27/2004 – 11/30/2005 Health Campaign for Sheltering Arms Childcare (M. Rogers) Role and effort: Consultant, 15% effort Grant number Funding agency: Georgia Healthcare Foundation Total costs: $92,000 Funding period: mm/dd/2004 – mm/dd/2004 Reproductive Health Needs of Women in Displaced Settings (M Rogers) Role and effort: Director, 20% effort Grant number Funding agency: CDC Foundation Total costs: $60,000 Funding period: mm/dd/2003 – mm/dd/2005 Title of grant: Environmental Education for Children (M. Rogers) Role and effort: Co-director, 25% effort Grant number Funding agency: ATSDR Total costs: $150,000 Funding period: mm/dd/2003 – mm/dd/2004 AIDS Orphans in Rwanda (M. Rogers) Role and effort : Director, 20% Grant number Funding agency: World Bank Total costs: $60,000 Funding period: mm/dd/2003 – mm/dd/2003 Evaluation of Parenting Course (M. Rogers) Role and effort: Co-director, 20% effort Grant number Funding agency: Regional Head Start Office Total costs: $68,000 Funding period: mm/dd/2003 – mm/dd/2003 Title of the grant: Parenting in the Real World (M. Rogers)
Martha F. Rogers, M.D., FAAP – August 2012
6
Role and effort: Director, 40% effort Grant number Funding agency: Robert Wood Johnson Foundation Total costs: $250,000 Funding period: mm/dd/2002 – mm/dd/2004 Title of grant: Center for Child Wellbeing (Mark Rosenberg) Role and % effort : Director, 100% Grant number Funding Agency: Robert Wood Foundation Total costs: $400,000 Funding period: mm/dd/2001 – mm/dd/2004 Child Needs Assessment Toolkit (M. Rogers) Role and effort : Director, 25% effort Grant number Funding agency: World Bank Total costs: $60,000 Funding period: mm/dd/2001 – mm/dd/2003
SCHOLARSHIP: PUBLICATIONS
Original Articles in Peer-Reviewed Journals (in reverse chronological order; please include the PubMedCentral ID Number (PMCID) if available)
Rogers MF, Kaplan AM, Ben-Ora A. Fetal hydrocephalus: use of ultrasound in diagnosis and management. Perinatology-Neonatology 1980;4:31-34.
Rogers MF, Morens DM, Stewart JA, et al. National case-control study of Kaposi's sarcoma and
Pneumocystis carinii pneumonia in homosexual men: part 2, laboratory results. Ann Intern Med 1983;99:151-158.
Jaffe HW, Choi K, Thomas PA, Haverkos HW, Auerbach DM, Guinan ME, Rogers MF, et al.
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: part 1, epidemiologic results. Ann Intern Med 1983;99:145-150.
Rogers MF, Schonberger LB, Hurwitz ES, Rowley DL. National Reye syndrome surveillance,
1982. Pediatrics 1985;75:260-264. Hurwitz ES, Barrett M, Rogers MF, Schonberger LB. Grade I Reye's syndrome. [Letter to ed]. N
Engl J Med 1984;310:128-129. Rogers MF, Schonberger LB, Hurwitz ES, Rowley DL. National Reye syndrome Surveillance,
Martha F. Rogers, M.D., FAAP – August 2012
7
1982. February edition of MMWR Quarterly Summary. Patriarca PA, Rogers MF, Morens DM, et al. Kawasaki syndrome: association with the
application of rug shampoo. Lancet 1982;2:578-80. Centers for Disease Control Task Force on Kaposi's Sarcoma and Opportunistic Infections.
Epidemiologic aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. N Engl J Med 1982;306:248-52.
Rogers MF. AIDS in children: a review of the clinical, epidemiologic and public health aspects.
Pediatric Infectious Disease 1985;4:230-236. Rogers MF, Budnick LD, Kirson I, et al. An outbreak hemolytic-uremic syndrome in
Sacramento, California. West J Med l986;l44:169-73. Rogers MF, Kochel R, Hurwitz ES, et al. Kawasaki syndrome: is exposure to rug shampoo
important? AJDC l985;l39:777-779. Rogers MF, Rutherford GW, Alexander SR, et al. A population-based study of
hemolytic-uremic syndrome in Oregon, 1979-1982. Am J Epidemiol l986;l23:137-42. Rogers MF, Lifson, AR. AIDS and HTLV-III/LAV infection in adolescents. Seminars in
Adolescent Med l986;2:l63. Rogers MF, Ewing EP, Warfield D, et al. Virologic studies of HTLV-III/LAV in pregnancy: case
report of a woman with AIDS. Obstet Gynecol l986;68:25. Friedland GH, Saltzman BR, Rogers MF, et. al. Lack of transmission of HTLV-III/LAV infection to
household contacts of patients with AIDS and AIDS related complex with oral candidiasis. N Engl J Med l986;3l4:344-49.
Barrett MJ, Hurwitz ES, Schonberger LB, Rogers MF. Changing epidemiology of Reye
syndrome in the United States. Pediatrics 1986; 77:598-602. Rogers MF. AIDS in children. Pediatria l986; 24:l22. Rogers MF. Pediatric AIDS. New York Medical Quarterly l987; 7:68-73. Rogers MF. The epidemiology of pediatric HTLV-III/LAV infection. In: Wormser GP, ed. AIDS
and other manifestations of human immunodeficiency virus infection. New York: Noyes publications, l987:36-47.
Martha F. Rogers, M.D., FAAP – August 2012
8
Rogers MF. The control of perinatally acquired HIV infection and the care of infected mothers,
infants, and children. West J Med l987;l47:l09-ll0. Rogers MF, Thomas PA, Starcher ET, Noa MC, Bush TJ, Jaffe HW. AIDS in children: report of
the Centers for Disease Control national surveillance, l982-l985. Pediatrics l987;79:l008-l0l4. Rogers MF, Williams WW. AIDS in blacks and Hispanics: implications for prevention. Issues in
Science and Technology l987;3:89-94. Rogers MF. Pediatric HIV infection: epidemiology, etiopathogenesis, and transmission.
Pediatric Annals 1988;17:324-331. Rogers MF. Perinatal HIV-1 infection. In: Kaslow RA, Francis D, eds. The epidemiology of AIDS.
New York: Oxford University Press, 1989:231-241. Rogers MF. AIDS: what parents should know to protect themselves and their families. PTA
Today l987;l2:l2-l3. Bennett JV, Holmberg SD, Rogers MF, Solomon SL. Infectious and Parasitic Diseases. In: Amler
RW, Dull HB, eds. closing the gap: the burden of unnecessary illness. New York: Oxford University Press, l987:l02-ll4.
Kinney JS, Gross TP, Porter CC, Rogers MF, Schonberger LB, Hurwitz ES. Hemolytic-uremic
syndrome: a population-based study in Washington, DC, and Baltimore Maryland. Am J Public Health 1988;78:64-65.
Rogers, MF. Classification system for human immunodeficiency virus (HIV) infection in
children under l3 years of age. In: Schinazi RF, Nahmias AJ, eds. AIDS in children, Adolescents and Heterosexual Adults. New York: Elsevier, l988:235-240.
Rogers MF. How do children acquire AIDS? Nebraska Perinatal Letter 1988;3:5-6. Rogers MF. Breast-feeding and HIV infection. Lancet 1987;2:1278. Rogers MF, Oleske J, Scott GB, Haverkos HW, Meade PB. AIDS in mothers and babies. Cont.
OB/GYN 1985;SI:126-141. Onorato IM, Orenstein WA, Hinman AR, Rogers MF, Koplan JP. Immunization of asymptomatic
HIV-infected children with measles vaccine: assessment of risks and benefits. Medical Decis Making l989;9:76-83.
Martha F. Rogers, M.D., FAAP – August 2012
9
Koonin LM, Ellerbrock TV, Atrash HK, Rogers MF, et al. Pregnancy- associated deaths due to
AIDS in the United States. JAMA 1989;251:1306-1309. Selwyn PA, Schoenbaum EE, Rogers MF, Davenny K, et al. Prospective study of human
immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989;261:1289-1294.
Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny K, Rogers MF, Feiner C, Friedland G.
Risk factors for HIV infection in IV drug users. N Engl J Med 1989;321:874-879. Rogers MF, Ou C-Y, Rayfield M, et al. Use of the polymerase chain reaction for early detection
of HIV proviral sequences in infants born to HIV-seropositive mothers. N Engl J Med 1989;320:1649-1654.
Rogers MF, White C, Sanders R, et al. Lack of evidence of transmission of HIV from infected
children to their household contacts. Pediatrics 1990;85:210-214. Selwyn PA, Carter RJ, Schoenbaum EE, Robertson VJ, Klein RS, Rogers, MF. Knowledge of HIV
antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA l989; 26l:3567-3571.
Rogers MF, Schochetman G. HIV infection in infants. In: Testing for AIDS and other retrovirus
infections: a practical desk reference. New York: Springer-Verlag, 1990: (in press). Ellerbrock TV, Rogers MF. Epidemiology of HIV infection in women in the United States. In:
Minkoff H. (in press). Jones DS, Rogers MF. Human immunodeficiency virus infection in children in day care.
Seminars in pediatric infectious diseases 1990;1:280-286. Friedland G, Kahl P, Saltzman B, Rogers M, Feiner C, Mayers M, Schable C, Klein RS. Additional
evidence for lack of transmission of HIV infection by close interpersonal (casual) contact. AIDS l990, 4:639-644.
Rogers MF, Ou C-Y, Kilbourne B, Schochetman G. Advances and problems in the diagnosis of
HIV infection in infants. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. Baltimore:Williams & Wilkins, 1991:159-174.
Bennett JV, Rogers MF. Child survival and perinatal infections with human immunodeficiency
virus. AJDC 1991; 145:1242-1247.
Martha F. Rogers, M.D., FAAP – August 2012
10
Caldwell MB, Rogers MF. Epidemiology of pediatric HIV infection. Pediatr Clin North Am
1991;38:1-16. Rogers MF, Ou C-Y, Kilbourne B, Schochetman G. Advances and problems in the diagnosis of
human immunodeficiency virus infection in infants. Pediatr Infect Dis J 1991;10:523-531. Rogers MF, Ou C-Y, Kilbourne B, Schochetman G. Early identification of human
immunodeficiency virus infection in infants. J Pediatr 1991;118:490-491. Abrams EJ, Rogers MF. Paediatric HIV infection. Bailliere's Clinical Haematology 1991;4:xxx-
xxx. Parekh BS, Shaffer N, Pau C-P, Abrams E, Thomas P, Pollack H, Bamji M, Kaul A, Schochetman
G, Rogers M, George JR and the NYC Perinatal HIV Transmission Collaborative Study. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. AIDS 1991;5:1179-1184.
Peterson HB, Rogers MF. Perinatal transmission of HIV. In: DeVita VT, Hellman S, Rosenberg
SA, eds. AIDS: Etiology, diagnosis, treatment and prevention. Philadelphia: JB Lippincott Co., 1992:471-478
Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, Kohlenberg SH,
Castro KG, Dahan BA, Schable CA, Rayfield MA, Rogers MF. Transmission of human immunodeficiency virus (HIV) from an HIV-seronegative organ and tissue donor. N Engl J Med 1992; 326:726-32
Darrow WW, Peterman TA, Jaffe HW, Rogers MF, Curran JW, Beral V. Kaposi's sarcoma and
exposure to faeces. Lancet 1992;339:685 Rogers MF. Donor/recipient HIV testing: Balancing medical practice with public health. J
Transplant Coordination 1992; 2:54-56 Rogers MF, Kilbourne BW. Epidemiology of Pediatric HIV Infection. In: Wormser GP, ed.
AIDS and Other Manifestations of HIV Infection. New York: Raven Press, 1992:17-24 Simonds RJ, Rogers MF. Epidemiology of HIV Infection in Children. In: Crocker AC, Cohen HJ,
Kastner TA, eds. HIV infection and developmental disabilities. Baltimore: Paul H. Brookes Publishing Co. 1992:1-13
Kaplan JE, Abrams E, Shaffer N, Cannon RO, Kaul A, Krasinski K, Bamji M, Hartley RM, Roberts
Martha F. Rogers, M.D., FAAP – August 2012
11
B, Kilbourne B, Thomas P, Rogers M, Heneine W. Low risk of mother-to-child transmission of HTLV-II in non-breast-fed infants. J Infect Dis 1992
Jones DS, Byers RH, Bush TJ, Oxtoby MJ, Rogers MF. The epidemiology of transfusion-associated AIDS in children in the United States, 1981-1989. Pediatrics 1992; 89:123-127.
Ellerbrock TV, Lieb S, Harrington PE, Bush TJ, Schoenfisch SA, Oxtoby MJ, Howell JT, Rogers
MF, Witte JJ. Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med 1992; 327:1704-9.
Nesheim S, Lee F, Sawyer M, Jones D, Slade B, Shaffer N, Homes R, Grimes V, Rogers M,
Czerkinsky C, Nahmias A. Diagnosis of human immunodeficiency virus infection by enzyme-linked immunospot (ELISPOT) assays in a prospectively-followed cohort of infants of HIV-seropositive women. Pediatr Infect Dis J 1992; 11:635-9.
Parekh, B, Shaffer N, Schochetman G, Rogers MF, et al. Dynamics of maternal IgG antibody
decay and HIV-specific antibody synthesis in infants born to seropositive mothers. AIDS and Human Retroviruses . Rogers MF, Caldwell B, Simonds RJ, Gwinn M. Epidemiology of pediatric human
immunodeficiency virus infection in the United States. Ann of the New York Academy of Sciences 1993;693:4-8.
Simonds RJ, Rogers MF. USPHS guidelines for prevention of transmission of HIV through
transplantation of human tissues and organs. J Transplant Coordination 1993;3:154-1556. Simonds RJ, Oxtoby MJ, Caldwell MB, Gwinn ML, Rogers MF. Pneumocystis carinii pneumonia
among US children with perinatally acquired HIV infection. JAMA 1993;270:470-3. Fowler MG, Mofenson L, Rogers M. Syposium-in-writing. Clinical Immunology and
Immunopathology 1994;71:1. Thomas PA, Weedon J, Krasinski K, Abrams E, Shaffer N, Matheson P, Bamji M, Kaul A, Hutson
D, Grimm KT, Beatrice ST, Rogers M, and the New York City Perinatal HIV Transmission Collaborative Study Group. Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infect Dis J 1994;13:489-95.
Rogers MF, Caldwell MB, Gwinn ML, Simonds RJ. Epidemiology of pediatric human
immunodeficiency virus infection in the United States. Acta Pediatr 1994;Suppl 400:5-7. Rogers MF, Jaffe HW. Reducing the risk of maternal-infant transmission of HIV: a door is open
Martha F. Rogers, M.D., FAAP – August 2012
12
[editorial]. N Engl J Med 1994;331:1222-3. Rogers MF, Schochetman G. HIV infection in children. In: Schochetman G, George JR, eds.
AIDS Testing. New York: Springer-Verlag 1994:266-83. Simonds RJ, Lindegren ML, Thomas P, Hanson D, Caldwell B, Scott G, Rogers MF. Prophylaxis
against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. N Engl J Med 1995;332:786-90.
Rogers MF, Mofenson LM, Moseley RR. Reducing the risk of perinatal HIV transmission
through zidovudine therapy: treatment recommendations and implications for perinatal HIV counseling and testing. JAMWA 1995;50:78-82.
Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M,
Hutson D, Grimm K, Kaul A, Bateman D, Rogers M, and the NYC Perinatal HIV Transmission collaborative Study Group. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995;96:451-458.
Matheson PB, Abrams EJ, Thomas P, Hernan MA, Thea DM, Lambert G, Krasinski K, Bamji M,
Rogers MF, Heagarty M, and the NYC Perinatal HIV Transmission Collaborative Study Group. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type I. J Infect Dis 1995;172:353-8.
Lobato MN, Spira TJ, Rogers MF, Laboratory Task Force. CD4+ T lymphocytopenia in children:
lack of evidence for a new AIDS agent. Pediatr Infect Dis J 1995;14:527-35. Rogers, MF. Epidemiology of HIV/AIDS in women and children in the United States. Acta
Scandinavia Paediatrica 1996. Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers MF. Cost-
effectiveness of short-course zidovudine to prevent perinatal HIV type i infection in a sub-Saharan African developing country setting. JAMA 1996;276:139-145.
Fowler MG, Rogers MF.Overview of perinatal HIV infection. J Nutrician 1996;126:2602S-7S. Smith DK, Rogers MF. Immunopathogenesis and detection of HIV infection in women and
newborns. Clin OBGYN 1996;39:277-91. Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan
ME. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention. Public Health Reports 1996;111:335-41.
Martha F. Rogers, M.D., FAAP – August 2012
13
Rogers MF, van Griensven GJ. AIDS 1997 Epidemiology: overview. AIDS 1997;11 Suppl A:S55-
6. Reggy AA, Rogers MF, Simonds RJ. Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent
perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis. [editorial] J Natl Cancer Inst 1997;89:1566-7.
Rogers MF. Epidemiology of HIV/AIDS in women and children in the USA. Acta Paediatr
Supplement 1997;421:15-6. DeCock K, Shaffer N, Wiktor S, Simonds RJ, Rogers M. Ethics of HIV Trials. Lancet
1997;350:1546-47. Rogers MF, Lindegren ML. Epidemiology of Pediatric HIV Infection. In: Wormser GP, ed. AIDS
and Other Manifestations of HIV Infection. New York: Lippencott-Raven Publishers, 1998:19-25 Simonds RJ, Rogers MF, Dondero TJ. Ethics of placebo-controlled trials of zidovudine to
prevent the perinatal transmission of HIV in the Third World [letter; comment] N Engl J Med 1998;338:836-7.
Bangkok Collaborative Perinatal HIV Transmission Study Group. The Bangkok short-course
zidovudine trial to reduce perinatal HIV transmission: summary of findings and operational issues. Prenat Neonat Med 1999;4(Suppl 1):1-7.
Rogers MF, Shaffer Nathan. Reducing the risk of maternal-infant transmission of HIV by
attacking the virus. N Engl J Med 1999;341:441-443. Lindegren ML, Byers RH, Thomas P, Davis SF, Caldwell B, Rogers MF, Gwinn M, Ward JW,
Fleming PL. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999;282:577-579 DeCock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, Alnwick DJ, Rogers M, Shaffer
N. Prevention of mother-to-child HIV transmission in resource-poor countries. JAMA 2000;283:1175-1182.
Rogers MF, guest ed. HIV/AIDS in Infants, Children, and Adolescents. The Pediatric Clinics of
North America. February 2000. Rogers MF, Stockton PL. Organizational approaches to the HIV/AIDS Crisis, Centers for Disease
Control and Prevention. Annals New York Academy of Sciences
Martha F. Rogers, M.D., FAAP – August 2012
14
Kellerman SE, Sullivan PS, Lee LM, Lindegren ML, Rogers MF. Epidemiology: report from the 7th Conference on Retroviruses and Opportunistic Infections. JAMA [Newsline]. Available at: http://www.ama-assn.org/special/hiv/newsline/conferen/retro00/retro00.htm. Accessed 3/29/00. [R]
Zaff JF, Smith DC, Rogers MF, Leavitt CH, Halle TG, Bornstein MH. In: Bornstein MH, Davidson
L, Keyes CL, Moore KA, & The Center for Child Well-being, eds. Well-being: positive development across the life course. Mahwah, NJ: Erlbaum, (in press).
Leavitt C, Tonniges T, Rogers MF. Good nutrition—Imperative for positive development. In:
Bornstein MH, Davidson L, Keyes CL, Moore KA, & The Center for Child Well-being, eds. Well-being: positive development across the life course. Mahwah, NJ: Erlbaum, (in press).
Swartzendruber A, Rogers MF. Orphanhood and the Effects of HIV/AIDS on Children and
Families. HIV Forefront 2001;3:2-4. King S, Lindegrin ML, Rogers MF. Epidemiology of Pediatric HIV Infection in the United States.
In: Wormser G, ed. AIDS and other manifestations of HIV infection. New York, NY: Academic Press (in press).
Pregnancy and HIV infection: a European consensus on management. Newell ML, Rogers MF,
eds. AIDS 2002;16:Supplement 2. Achievements, Issues, and Challenges: Prevention of Mother-to-Child HIV Transmission in the
United States and in Resource-Limited Settings. Amer J OBGYN 2007;197, issue 3, supplement 1. (Guest Editor)
Patricia L. Riley, Stephen M. Vindigni, John Arudo, Agnes N. Waudo, Andrew Kamenju, Japheth
Ngoya, Elizabeth O. Oywer, Chris P. Rakuom, Marla E. Salmon, Maureen Kelley, Martha Rogers, Michael E. St. Louis, Lawrence H. Marum (2007) Developing a Nursing Database System in Kenya Health Services Research 42 (3p2) , 1389–1405 doi:10.1111/j.1475-6773.2007.00715
Gross J.M.,1 Riley P.L.,2 Kiriinya R.,3 Rakuom C.,4 Willy R.,4 Kamenju A.,3 Oywer E.,5 Wambua D.,5
Waudo, A.,3 Rogers M.F.1 Using Information Systems to Analyze the Impact of the Emergency Hire Plan on the Nursing Shortage and Nurse Distribution in Kenya. Bull World Health Organ 2010;88:824–830 | doi:10.2471/BLT.09.072678
Gross JM, Rogers M, Teplinsky I et al. The impact of outmigration on the nursing workforce in
Kenya. Health Services Research, in press Rogers M, Taylor A, Neisheim S. Prevention Perinatal Transmission of HIV: the National
Perspective. J Public Health Management Practice, 2010, 16(6), 505–508
Martha F. Rogers, M.D., FAAP – August 2012
15
Vindigni S, Riley P, Kimani F, Willy R, Warutere P, Sabatier J, Kiriinya K, Friedman M, Osumba M, Waudo A, Rakuom C, Rogers M. Kenya’s emergency hire nursing program: a pilot evalution of health service delivery in two districts. Human Resources for Health 2014;12:16
Wakaba M, Mbindyo P, Ochieng J, Todd J, Kiriinya R, Waudo A, Rakuom C, Noor A, Rogers M, English M.
The Public Sector Nursing Workforce in Kenya – A County Level Analysis. Human Resources for
Health 2014, 12:6
Appiagyei A, Kiriinya R, Gross J, Wambua D, Oywer E, Kamenju A, Higgins M, Riley P, Rogers M.
Using trends in training capacity and registration to inform the scale-up of the nursing workforce in Kenya. (in clearance)
Book Chapter (as APA citations, in reverse chronological order)
Book Reviews (as APA citations, in reverse chronological order)
Research Abstracts and Proceedings (as APA citations, in reverse chronological order)
Instructional Booklet (as APA citations, in reverse chronological order)
Educational Software (as APA citations, in reverse chronological order)
Video (as APA citations, in reverse chronological order)
Martha F. Rogers, M.D., FAAP – August 2012
16
SCHOLARSHIP: PRESENTATIONS
International Presentations (as APA citations, in reverse chronological order)
National Presentations (as APA citations, in reverse chronological order)
Local, State, and Regional Presentations (as APA citations, in reverse chronological order)
TEACHING ACTIVITIES
Courses Taught Dates NXXX Name of Course Role in course Fall NRSG 710 Principles in Health
Outcomes Research
Coordinator
Spring NRSG 733 Health Risk, Interventions, and Outcomes
Coordinator
Fall EPI 591 Epidemiology of HIV and STD Transmission
Guest lecturer
Fall
NRSG 701 Policy
Guest lecturer
Doctor of Philosophy in Nursing Advisement 2008-2012 2009 – present 2007 – 2010 2013 - Present
Dissertation Committee Member for Rebecca Wheeler Dissertation Committee Member for Hanna Demeke Dissertation Committee Member for Mabel Magowe Chair, Dissertation Committee for Jennifer Vanderlaan
Martha F. Rogers, M.D., FAAP – August 2012
17
Master of Science in Nursing Thesis Advisement Year
Name of Student, “Title of Thesis”, Role (i.e., Thesis Chair)
2003 Chassea Golden, MPH/MSN, “Barriors to PMTCT in Kenya”, (thesis advisor)
Master of Public Health Thesis Advisement 19XX-Present Name of Student, “Title of Thesis”, Role (i.e., Thesis Chair)
2002 Kate Meiners, MPH, “AIDS Orphans in Cameroon”, (thesis advisor)
2003 Alison Swint, MPH, “PMTCT in Kenya”, (thesis advisor)
2004 Rebecca Carter, MPH, “ Evaluation of a Family Health Campaign”
2005 Erin Jones, MPH, “AIDS Orphans”
2006 Cristin Haggard, MPH candidate, “Monitoring and Evaluation of OVC Projects”
2008 Jessica Gross, MPH candidate, “ Outmigration of Kenyan Nurses”
2010 Ashley Appiagyei, MPH candidate, “Nurse Training in Kenya”
2011 Megan Thompson, MPH candidate, “Disparities in Nurse Distribution in Kenya”
PROFESSIONAL AND UNIVERSITY SERVICE ACTIVITIES
Membership in Professional Organizations
Date Name of organization
1981-present American Academy of Pediatrics
1990-2000 Sigma Xi
1983-present EIS Alumni
1981-present Commissioned Officers Association
Editorships and Editorial Boards 19xx-Present Editor, Journal (italicized) 1995-2003
Editorial Board, AIDS
Manuscript Reviewer 19xx-Present Reviewer, Journal (italicized)
Martha F. Rogers, M.D., FAAP – August 2012
18
1985-Present Reviewer, New England Journal of Medicine
1995-Present Reviewer, AIDS
1985-Present Reviewer, JAMA
1990-Present Reviewer, American Journal of Pediatrics
1991-Present Reviewer, Lancet
1992-1999+ Reviewer, American J OBGYN
National and International Consultation
Year Activity
1982 Investigated unusual hepatitis-like illness in missionary population in Bangladesh.
1986 Responsible for initiating study of perinatal transmission of HIV in population of African women in Kinshasa, Zaire
Lectured in several foreign countries
1992- 1995 Appointed to Steering Committee for Epidemiological Research for the Global Program on
AIDS, World Health Organization
1994 Member UNAIDS Coordinating Committee for the Reduction of Perinatal Transmission of HIV
Travel to Thailand, Ivory Coast, and several other countries for consultation on clinical trials of AZT for the prevention of perinatal transmission of HIV
Responsible for coordinating and directing UNAIDS HIV collaborating center at CDC.
Directed project sponsored by the World Bank to assess needs of children orphaned by the HIV/AIDS epidemic.
1982 New Brunswick Task Force on Reye Syndrome and the Environment, New Brunswick, Canada, March
1982 NIH Consensus Conference on Reye Syndrome, Washington, D.C., May 1982.
1985 CDC Consultant Committee for School Attendance of HIV-Infected Children, June 1985. Responsible for publication of guidelines (MMWR 1985; 34:517)
1987 Chair, CDC Consultant Committee for Developing the Case Classification System for HIV in Children, September 1986. Document published (MMWR 1987; 36:225)
1987 Planning Committee for the Surgeon General's Conference on Pediatric AIDS, Philadelphia
1988 Member of the Secretary of HHS Task Force on Pediatric AIDS. March - August 1988.
Martha F. Rogers, M.D., FAAP – August 2012
19
1988 Consultant to National Association of State Boards of Education, June 1988. Document published and widely disseminated to education departments.
1989 Member of the Technical Panel on Prevention and Control of Infectious Diseases in Child Care Settings, American Academy of Pediatrics and American Public Health Association, June 1989-present.
1989 Member of the planning committee for the Fifth National Pediatric AIDS Conference
1989 Planning Committee for Surgeon General's Workshop on Pediatric AIDS
1989 Consultant for World Health Organization committee on early diagnosis of HIV infection in infants, October 1989.
1989 Member of the scientific advisory committee for conference "AIDS--The Implications for Mothers and Children", Paris, France
1989- 1990 CDC representative to the PHS Panel on Women, Adolescents, and Children with HIV Disease
and AIDS, Chaired by Drs. Antonia Novello and James Allen
1990 Member of the scientific review committee for the Sixth International Conference on AIDS
1990 Chair, Consultants Committee for the Development of Guidelines for the Prevention and Management of HIV Infection in Women and Their Children
1991 Member of planning committee for the Sixth Annual National Pediatric AIDS Conference
1990 Member of the scientific advisory committee for the International Symposium on AIDS and Reproduction, Genoa, Italy
1990 Chair, Technical Working Group for Strategic Planning for Prevention of HIV Infection in Women and Children. Coordinated working group composed of representatives from several national centers at CDC. Developed document that serves as guidepost for prevention activities.
1990 CDC Chair, PHS Conference on Early Diagnosis of HIV Infection in Infants. Washington, D.C.
1991 Member of the scientific review committee for the Seventh International Conference on AIDS.
1991 Chair, Consultants Committee for the Development of Guidelines for the Prevention of HIV Transmission from Transplantation of Tissues/Organs.
1991 CDC Representative to the PHS Workgroup on Organ and Tissue Transplantation. Report submitted to Dr. Mason 1991.
1991 Member, Epidemiology and Technology Transfer Subcommittee of the Acquired Immunodeficiency Syndrome Research Review Committee, National Institute of Allergy and Infectious Diseases, appointed July 1991.
Member, American Academy of Pediatrics Provisional Committee on AIDS
1992 Chair, Idiopathic CD4+ T-lymphocytopenia Syndrome Task Force, Appointed July 1992.
Martha F. Rogers, M.D., FAAP – August 2012
20
1993 Member, WHO Steering Committee on Epidemiological Research and Forecasting for the Global Program on AIDS
1994 Member, UNAIDS Committee for the Prevention of Mother-to-child Transmission of HIV Member, Scientific Advisory Board for the Antiretroviral Use in Pregnancy Registry
1994 Member, USPHS Task Force on the Prevention of Perinatal Transmission of HIV
1996 Member, Review committee for the Fogarty International Foundation, 1996
1998 Member, Program Advisory Committee for the Pediatric AIDS Foundation, 1998-present
1999 Member, Editorial Board of HIV Forefront
1999 Member, Department of HHS Workgroup on Use of Antiretroviral Agents for Prevention of Perinatal HIV Infection
2008 -2009 Member, PEPFAR Prevention of Mother-to-Child Transmission Panel
Visiting Professorships N/A
National and International Scientific Review
Year Name of Panel
1983-2000 Assumed the lead role in developing the following policy documents including organizing expert consultations, consensus building, writing, clearance, and dissemination.
1985 MMWR 1985;34:517. Education and Foster Care of Children Infected with Human T-lymphotropic Virus Type III/Lymphadenopathy-associated Virus.
1985 MMWR 1985;34:721. Recommendations for Prevention of Perinatal Transmission of Human T-lymphotropic Virus Type III/Lymphadenopathy-associated Virus and AIDS
1987 MMWR 1987;36:225. Classification System for HIV Infection in Children Under 13 Years of Age.
1994 MMWR 1994;43:RR-8. Guidelines for Preventing Transmission of HIV Through Transplantation of Human Tissues and Organs.
1995 MMWR 1995;44:RR-7. U.S. Public Health Service Recommendations for HIV Counseling and Voluntary Testing for Pregnant Women.
2001 MMWR 2001;50:RR-19. Revised Recommendations for HIV Screening of Pregnant Women.
Martha F. Rogers, M.D., FAAP – August 2012
21
Emory University Service Year Role, Name of Committee or Group
2002-2004 Member, International Affairs Committee
Nell Hodgson Woodruff School of Nursing Service N/A
Other Community Service Year Role, Name of Committee or Group
Volunteer technical assistance to Reach-Out, a non-profit organization in Kenya